State Street Corporation (ACAD) discloses 5.3% Acadia Pharma stake on 13G
State Street Corporation has disclosed a 5.3% beneficial ownership stake in Acadia Pharmaceuticals Inc. (ACAD) through a Schedule 13G SEC filing. This translates to 9,076,212 shares of common stock, managed across various State Street Global Advisors entities. The filing indicates shared voting power over …